Ftse Mib
38.819,62
0,78%
DAX
23.419,48
1,30%
S&P 500
5.738,52
-1,78%
NASDAQ
18.069,26
-2,61%
Bitcoin
89.932,60
-0,77%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kazia Therapeutics Ltd (KZIA) Kazia Therapeutics Ltd (KZIA) Notizie

Kazia Therapeutics Ltd

KZIA
0,8023
0,0123 (1,56%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:43:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/2/202512:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:53EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202514:46PRNUSKazia Therapeutics and the Hebrew University of Jerusalem..
06/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
05/2/202522:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/2/202514:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202522:31EDGAR2Form F-1 - Registration statement for certain foreign..
30/1/202514:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202514:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202513:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202513:30PRNUSKazia Therapeutics announces the launch of a groundbreaking..
16/1/202516:40EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
14/1/202522:00PRNUSKazia Therapeutics Announces Closing of $2.0 Million..
13/1/202514:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202514:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202514:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202514:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202515:58PRNUSKazia Therapeutics Announces $2.0 Million Registered Direct..
31/12/202414:49EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/12/202414:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/12/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/12/202414:00PRNUSKazia Therapeutics Provides Update on Paxalisib Regulatory..
11/12/202414:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202414:00PRNUSKazia Therapeutics to Present Data Highlighting Synergistic..
03/12/202422:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/12/202422:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/11/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
27/11/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
15/11/202422:02EDGAR2Form 20-F - Annual and transition report of foreign private..
14/11/202422:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202401:53EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202413:30PRNUSKazia Therapeutics Announces Granting of Type C Meeting with..
01/11/202421:05EDGAR2Form NT 20-F - Notification of inability to timely file Form..
24/10/202414:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:22EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
15/10/202413:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202422:57EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202414:45PRNUSKazia Therapeutics Announces Presentation of Promising Phase..
Apertura: 0,79 Min: 0,79 Max: 0,85
Chiusura: 0,79

La tua Cronologia

NASDAQ
KZIA
Kazia Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci